Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients

A Feasibility Study to Determine the Up-regulation of Anti-inflammatory Cytokines in Whole Blood From Patients With Osteoarthritis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01050894

Enrollment

105

Registered

2010-01-18

Start date

2010-05-31

Completion date

2012-01-31

Last updated

2017-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

osteoarthritis

Brief summary

This is a feasibility study to determine if anti-inflammatory cytokines can be concentrated from patients with osteoarthritis.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* radiographic evidence of osteoarthritis * signed informed consent

Exclusion criteria

* Pregnancy * \< 18 years of age * blood clotting disorder or active hematologic cancer * undergoing chemotherapy * history of rheumatoid arthritis * septic joint or fracture * active infection or history of chronic infection * use of cytokine blocking drugs with the last 6 months * intra-articular steroid or hyaluronic acid (HA) injection within last 6 months

Design outcomes

Primary

Measure	Time frame
Measure anti-inflammatory cytokines	immediately after processing

Countries

United States

Outcome results